tiprankstipranks
Fresenius Medical Care AG & Co. KGaA (MX:FMEN)
LSE:FMEN
Mexico Market
FMEN
Fresenius Medical Care AG & Co. KGaA
RESEARCH TOOLSreports

Fresenius Medical Care AG & Co. KGaA (FMEN) Stock Forecast & Price Target

― Followers
See the Price Targets and Ratings of:

FMEN Analyst Ratings

Moderate Sell
11Ratings
Moderate Sell
1 Buy
5 Hold
5 Sell
Based on 11 analysts giving stock ratings to
Fresenius
Medical Care AG & Co. KGaA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

FMEN Stock 12 Month Forecast

Average Price Target

$738.88
Based on 11 Wall Street analysts offering 12 month price targets for Fresenius Medical Care AG & Co. KGaA in the last 3 months. The average price target is $738.88 with a high forecast of $878.07 and a low forecast of $589.97. The average price target represents a ― change from the last price of ―.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"588":"$588","879":"$879","660.75":"$660.8","733.5":"$733.5","806.25":"$806.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":878.072762917,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$878.07</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":738.8834261052223,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$738.88</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":589.9705014,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$589.97</span>\n  </div></div>","useHTML":true}}],"tickPositions":[588,660.75,733.5,806.25,879],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,778.14,785.827135609,793.514271218,801.201406827,808.888542436,816.575678045,824.262813654,831.949949263,839.637084872,847.324220481,855.0113560899999,862.698491699,870.385627308,{"y":878.072762917,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,778.14,775.1202635465555,772.100527093111,769.0807906396667,766.0610541862222,763.0413177327778,760.0215812793333,757.001844825889,753.9821083724445,750.962371919,747.9426354655556,744.9228990121112,741.9031625586667,{"y":738.8834261052223,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,778.14,763.6654231846154,749.1908463692307,734.7162695538461,720.2416927384616,705.767115923077,691.2925391076923,676.8179622923077,662.343385476923,647.8688086615384,633.3942318461538,618.9196550307693,604.4450782153846,{"y":589.9705014,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":865.815,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 8</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":865.815,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":865.815,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 12</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":865.815,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":798.474,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":798.474,"date":1769904000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":798.474,"date":1772323200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":798.474,"date":1775001600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":759.157,"date":1777593600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":753.47,"date":1780272000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":778.14,"date":1782864000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 17</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":778.14,"date":1785542400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":778.14,"date":1788220800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 12</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$878.07Average Price Target$738.88Lowest Price Target$589.97
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on MX:FMEN
Anchal Verma
J.P. Morgan
J.P. Morgan
―
Sell
―
Reiterated
09/09/26
Jefferies Analyst forecast on MX:FMEN
James Vane
Jefferies
Jefferies
$609.64→$589.97
Sell
―
Reiterated
08/11/26
Jefferies Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
DZ BANK AG Analyst forecast on MX:FMEN
Unknown Analyst
DZ BANK AG
Not Ranked
DZ BANK AG
―
Buy
―
Reiterated
08/06/26
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Buy from DZ BANK AG
Barclays Analyst forecast on MX:FMEN
Hassan Al-Wakeel
Barclays
Barclays
$904.62→$875.12
Hold
―
Reiterated
08/06/26
Barclays Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Goldman Sachs Analyst forecast on MX:FMEN
Richard Felton
Goldman Sachs
Goldman Sachs
$845.62→$766.96
Hold
―
Reiterated
08/05/26
Goldman Sachs Remains a Hold on Fresenius Medical Care AG & Co. KGaA (0H9X)
Morgan Stanley Analyst forecast on MX:FMEN
Aisyah Noor
Morgan Stanley
Morgan Stanley
$629.3→$609.64
Sell
―
Reiterated
08/05/26
Fresenius Medical price target lowered to EUR 31 from EUR 32 at Morgan StanleyFresenius Medical price target lowered to EUR 31 from EUR 32 at Morgan Stanley
UBS Analyst forecast on MX:FMEN
Graham Doyle
UBS
UBS
$727.63→$707.96
Sell
―
Reiterated
08/04/26
UBS Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Bernstein Analyst forecast on MX:FMEN
Susannah Ludwig
Bernstein
Bernstein
$878.07
Hold
―
Reiterated
08/04/26
Bernstein Keeps Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Deutsche Bank Analyst forecast on MX:FMEN
Falko Friedrichs
Deutsche Bank
Deutsche Bank
$786.63
Hold
―
Reiterated
08/04/26
Deutsche Bank Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Bank of America Securities Analyst forecast on MX:FMEN
Anna Ractliffe
Bank of America Securities
Bank of America Securities
$629.3
Sell
―
Reiterated
08/03/26
Fresenius Medical Care: Sell Rating Reiterated as Growth Concerns Persist and $32 Price Target Remains Unchanged
Citi Analyst forecast on MX:FMEN
Veronika Dubajova
Citi
Citi
$786.63→$806.29
Hold
―
Reiterated
07/17/26
Fresenius Medical price target raised to EUR 41 from EUR 40 at CitiFresenius Medical price target raised to EUR 41 from EUR 40 at Citi
Kepler Capital Analyst forecast on MX:FMEN
Oliver Reinberg
Kepler Capital
Kepler Capital
$845.62
Hold
―
Reiterated
05/05/26
Kepler Capital Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
mwb research Analyst forecast on MX:FMEN
Harald Hof
mwb research
mwb research
$904.62→$924.29
Buy
―
Upgraded
01/12/26
Berenberg Bank Analyst forecast on MX:FMEN
Sam England
Berenberg Bank
Berenberg Bank
$1,179.94
Buy
―
Reiterated
12/03/25
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Buy from Berenberg Bank
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on MX:FMEN
Anchal Verma
J.P. Morgan
J.P. Morgan
―
Sell
―
Reiterated
09/09/26
Jefferies Analyst forecast on MX:FMEN
James Vane
Jefferies
Jefferies
$609.64→$589.97
Sell
―
Reiterated
08/11/26
Jefferies Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
DZ BANK AG Analyst forecast on MX:FMEN
Unknown Analyst
DZ BANK AG
Not Ranked
DZ BANK AG
―
Buy
―
Reiterated
08/06/26
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Buy from DZ BANK AG
Barclays Analyst forecast on MX:FMEN
Hassan Al-Wakeel
Barclays
Barclays
$904.62→$875.12
Hold
―
Reiterated
08/06/26
Barclays Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Goldman Sachs Analyst forecast on MX:FMEN
Richard Felton
Goldman Sachs
Goldman Sachs
$845.62→$766.96
Hold
―
Reiterated
08/05/26
Goldman Sachs Remains a Hold on Fresenius Medical Care AG & Co. KGaA (0H9X)
Morgan Stanley Analyst forecast on MX:FMEN
Aisyah Noor
Morgan Stanley
Morgan Stanley
$629.3→$609.64
Sell
―
Reiterated
08/05/26
Fresenius Medical price target lowered to EUR 31 from EUR 32 at Morgan StanleyFresenius Medical price target lowered to EUR 31 from EUR 32 at Morgan Stanley
UBS Analyst forecast on MX:FMEN
Graham Doyle
UBS
UBS
$727.63→$707.96
Sell
―
Reiterated
08/04/26
UBS Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Bernstein Analyst forecast on MX:FMEN
Susannah Ludwig
Bernstein
Bernstein
$878.07
Hold
―
Reiterated
08/04/26
Bernstein Keeps Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Deutsche Bank Analyst forecast on MX:FMEN
Falko Friedrichs
Deutsche Bank
Deutsche Bank
$786.63
Hold
―
Reiterated
08/04/26
Deutsche Bank Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Bank of America Securities Analyst forecast on MX:FMEN
Anna Ractliffe
Bank of America Securities
Bank of America Securities
$629.3
Sell
―
Reiterated
08/03/26
Fresenius Medical Care: Sell Rating Reiterated as Growth Concerns Persist and $32 Price Target Remains Unchanged
Citi Analyst forecast on MX:FMEN
Veronika Dubajova
Citi
Citi
$786.63→$806.29
Hold
―
Reiterated
07/17/26
Fresenius Medical price target raised to EUR 41 from EUR 40 at CitiFresenius Medical price target raised to EUR 41 from EUR 40 at Citi
Kepler Capital Analyst forecast on MX:FMEN
Oliver Reinberg
Kepler Capital
Kepler Capital
$845.62
Hold
―
Reiterated
05/05/26
Kepler Capital Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
mwb research Analyst forecast on MX:FMEN
Harald Hof
mwb research
mwb research
$904.62→$924.29
Buy
―
Upgraded
01/12/26
Berenberg Bank Analyst forecast on MX:FMEN
Sam England
Berenberg Bank
Berenberg Bank
$1,179.94
Buy
―
Reiterated
12/03/25
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Buy from Berenberg Bank
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Fresenius Medical Care AG & Co. KGaA

3 Months
James VaneJefferies
Success Rate
24/52 ratings generated profit
46%
Average Return
-3.00%
Copying James Vane's trades and holding each position for 3 Months would result in 46.15% of your transactions generating a profit, with an average return of -3.00% per trade.
1 Year
James VaneJefferies
Success Rate
28/52 ratings generated profit
54%
Average Return
-2.38%
Copying James Vane's trades and holding each position for 1 Year would result in 53.85% of your transactions generating a profit, with an average return of -2.38% per trade.
2 Years
James VaneJefferies
Success Rate
26/52 ratings generated profit
50%
Average Return
-5.47%
Copying James Vane's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -5.47% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

FMEN Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
0
0
0
0
0
Buy
2
1
1
1
1
Hold
10
8
8
8
7
Sell
11
13
17
16
12
Strong Sell
0
0
0
0
0
total
23
22
26
25
20
In the current month, FMEN has received 1 Buy Ratings, 7 Hold Ratings, and 12 Sell Ratings. FMEN average Analyst price target in the past 3 months is 738.88.
Each month's total comprises the sum of three months' worth of ratings.

FMEN Financial Forecast

FMEN Earnings Forecast

Next quarter’s earnings estimate for FMEN is $20.74 with a range of $18.08 to $23.89. The previous quarter’s EPS was $22.12. FMEN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year FMEN has Performed in-line its overall industry.
Next quarter’s earnings estimate for FMEN is $20.74 with a range of $18.08 to $23.89. The previous quarter’s EPS was $22.12. FMEN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year FMEN has Performed in-line its overall industry.

FMEN Sales Forecast

Next quarter’s sales forecast for FMEN is $97.26B with a range of $95.23B to $100.89B. The previous quarter’s sales results were $95.72B. FMEN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year FMEN has Performed in-line its overall industry.
Next quarter’s sales forecast for FMEN is $97.26B with a range of $95.23B to $100.89B. The previous quarter’s sales results were $95.72B. FMEN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year FMEN has Performed in-line its overall industry.

FMEN Stock Forecast FAQ

What is MX:FMEN’s average 12-month price target, according to analysts?
Based on analyst ratings, Fresenius Medical Care AG & Co. KGaA’s 12-month average price target is 738.88.
    What is MX:FMEN’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MX:FMEN, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Fresenius Medical Care AG & Co. KGaA a Buy, Sell or Hold?
        Fresenius Medical Care AG & Co. KGaA has a consensus rating of Moderate Sell, which is based on 1 buy ratings, 5 hold ratings and 5 sell ratings.
          What is Fresenius Medical Care AG & Co. KGaA’s share price target?
          The average share price target for Fresenius Medical Care AG & Co. KGaA is 738.88. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $878.07 ,and the lowest forecast is $589.97. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Fresenius Medical Care AG & Co. KGaA?
            Fresenius Medical Care AG & Co. KGaA’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 11 Wall Streets Analysts.
              How can I buy shares of Fresenius Medical Care AG & Co. KGaA?
              To buy shares of MX:FMEN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.